11-62666641-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001043229.2(CSKMT):c.313G>T(p.Gly105Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001043229.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSKMT | NM_001043229.2 | c.313G>T | p.Gly105Trp | missense_variant | Exon 3 of 3 | ENST00000532971.2 | NP_001036694.1 | |
LBHD1 | NM_024099.5 | c.538+882C>A | intron_variant | Intron 4 of 6 | ENST00000354588.8 | NP_077004.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSKMT | ENST00000532971.2 | c.313G>T | p.Gly105Trp | missense_variant | Exon 3 of 3 | 2 | NM_001043229.2 | ENSP00000431287.1 | ||
LBHD1 | ENST00000354588.8 | c.538+882C>A | intron_variant | Intron 4 of 6 | 1 | NM_024099.5 | ENSP00000346600.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.313G>T (p.G105W) alteration is located in exon 3 (coding exon 2) of the METTL12 gene. This alteration results from a G to T substitution at nucleotide position 313, causing the glycine (G) at amino acid position 105 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.